catechin has been researched along with Pneumonia, Viral in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Barrientos, RM; Butler, MJ | 1 |
Catherine DeSoto, M | 1 |
Bertoldi, M; Campagnari, R; Crupi, R; Cuzzocrea, S; Di Paola, R; Menegazzi, M | 1 |
Grebenchikov, OA; Zinovkin, RA | 1 |
Chen, LJ; Hou, W; Li, JL; Li, N; Ling, JX; Liu, YY; Luo, F; Wei, F; Xiong, HR; Yang, ZQ | 1 |
1 review(s) available for catechin and Pneumonia, Viral
Article | Year |
---|---|
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Topics: Anti-Inflammatory Agents; Antioxidants; Autoimmune Diseases; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; NF-kappa B; Pandemics; Plant Extracts; Pneumonia, Viral; Pulmonary Fibrosis; SARS-CoV-2; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor | 2020 |
4 other study(ies) available for catechin and Pneumonia, Viral
Article | Year |
---|---|
Reply to the Letter to the Editor: Regional differences in dietary use of immune-modulating catechins should be investigated regarding COVID-19.
Topics: Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; Diet; Immune System; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19.
Topics: Antioxidants; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
Topics: Animals; Antioxidants; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Dimethyl Fumarate; Female; Humans; Immunosuppressive Agents; Inflammation; Isothiocyanates; Male; Mice; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oxidative Stress; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Resveratrol; SARS-CoV-2; Signal Transduction; Sulfoxides; Thiosulfates | 2020 |
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea.
Topics: Animals; Antiviral Agents; Camellia sinensis; Catechin; Cell Line; Cell Survival; Dogs; Dose-Response Relationship, Drug; Erythrocytes; Guinea Pigs; Hemagglutination Tests; Hemagglutination, Viral; Influenza A Virus, H1N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Pneumonia, Viral; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2012 |